NOX1 promotes myocardial fibrosis and cardiac dysfunction <i>via</i> activating the TLR2/NF-&#954;B pathway in diabetic cardiomyopathy.

NOX1 promotes myocardial fibrosis and cardiac dysfunction via activating the TLR2/NF-κB pathway in diabetic cardiomyopathy.

Zhang, Dandan; Li, Yilan; Wang, Weijie; Lang, Xueyan; Zhang, Yanxiu; Zhao, Qianqian; Yan, Jingru; Zhang, Yao.

Afiliación

Zhang D; Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Li Y; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, China.
Wang W; Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Lang X; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, China.
Zhang Y; Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhao Q; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, China.
Yan J; Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhang Y; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, China.

Front Pharmacol ; 13: 928762, 2022.

Article en En | MEDLINE | ID: mdl-36225554